Trombocitopenia por agregados plaquetarios: reporte de caso

Esteban Adrian Reiban Espinoza, Yesenia Alexandra Sanmartin Calle, Esteban Alexander Reibán Sanmartín, Esteban Alexander Reibán Sanmartín (Autor de Correspondencia)

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

Resumen

Introduction: EDTA (ethylenediamine tetraacetic acid) –induced by pseudothrombocytopenia is a platelet agglutination phenomenon that occurs in vitro, which are mediated by anti-platelet antibodies of the IgG, IgA or IgM type directed against the glycoprotein complex IIb / IIIa of the platelet membrane .Clinical case: This is a clinical case of a 59-years-old patient undergoing aortic valve replacement, clinically with a favorable evolution during the postoperative period, however, in control studies, severe thrombocytopenia was recorded, which led to questioning the use of anticoagulants and the need for platelet transfusion. When carrying out complementary studies, aggregated platelet were found in the peripheral blood smear, later, a serial platelet count and comparison of the platelet histogram were performed, classifying the case as pseudotrombocytopenia.Conclusion: Thrombocytopenia due to aggregated platelet is a low incidence condition (0.07% to 0.1%). It is due to the aggregation of platelets in vitro associated with the use of anticoagulants [frequently ethylenediamine tetra acetic (EDTA)]; in the present case it was also associated with the use of sodium citrate. This problem is not associated with bleeding; however its lack of knowledge leads to unnecessary diagnostic and therapeutic procedures
Idioma originalEspañol
PublicaciónRevista de la Facultad de Ciencias Médicas de la Universidad de Cuenca
EstadoPublicada - 1 ene. 2020

Palabras clave

  • Anticoagulantes; Aregación plaquetaria

Citar esto